Innoviva, Inc.
Status: Publicly traded
Direct answer
Innoviva, Inc. is publicly traded on NASDAQ under the ticker INVA.
Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs...
Can you invest in Innoviva, Inc.?
Yes. Innoviva, Inc. trades publicly on NASDAQ as INVA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Innoviva, Inc.
Detailed equity research is provided by MarketSnap.